Clinical Trial Update: Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage [Phase 3]

View source ↗

Summary

Phase 3 trial updating the randomisation of an antifibrinolytic for significant hemorrhage; no results are described in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhage

Drugs mentioned

• antifibrinolytic

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Hemorrhage | Phase 3 | Status: COMPLETED